Wells Fargo’s PharmaCyte Biotech PMCB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-55
| Closed | -$130 | – | 6857 |
|
|
2024
Q1 | $130 | Hold |
55
| – | – | ﹤0.01% | 6206 |
|
|
2023
Q4 | $119 | Buy |
55
+2
| +4% | +$4 | ﹤0.01% | 6278 |
|
|
2023
Q3 | $111 | Sell |
53
-132
| -71% | -$276 | ﹤0.01% | 6367 |
|
|
2023
Q2 | $529 | Buy |
185
+56
| +43% | +$160 | ﹤0.01% | 6168 |
|
|
2023
Q1 | $375 | Sell |
129
-12
| -9% | -$35 | ﹤0.01% | 6295 |
|
|
2022
Q4 | $413 | Buy |
141
+3
| +2% | +$9 | ﹤0.01% | 6107 |
|
|
2022
Q3 | $0 | Sell |
138
-1
| -0.7% | – | ﹤0.01% | 6851 |
|
|
2022
Q2 | $0 | Buy |
139
+11
| +9% | – | ﹤0.01% | 6997 |
|
|
2022
Q1 | $0 | Buy |
128
+1
| +0.8% | – | ﹤0.01% | 7087 |
|
|
2021
Q4 | $0 | Buy |
127
+101
| +388% | – | ﹤0.01% | 7075 |
|
|
2021
Q3 | $0 | Buy |
+26
| New | – | ﹤0.01% | 6997 |
|